DoD Peer Reviewed Cancer, Impact Award | W81XWH 21 PRCRP IPA

Opportunity Information: Apply for W81XWH 21 PRCRP IPA

The DoD Peer Reviewed Cancer Research Program (PRCRP) Impact Award (FY21) is a Department of Defense funding opportunity designed to push forward hypothesis-driven cancer research that is far enough along to credibly influence patient care in the near term. Rather than supporting early-stage discovery work, this mechanism targets mature projects that are already built on a solid base of prior findings and are ready to address a critical scientific or clinical problem in cancer. The program is looking for studies that, if successful, would make a substantial and measurable difference quickly, not a modest or incremental step. A key theme running through the announcement is translation: proposals should be positioned to move promising results toward real-world clinical use, including treatment and prevention strategies.

A central requirement is that the proposed work clearly demonstrates major near-term impact within at least one of the FY21 PRCRP Topic Areas and also aligns with one of the program's overarching challenges (or another clearly justified, high-priority cancer problem). The award emphasizes outcomes that matter to patients, so applicants are expected to make a convincing case for how their study could transform research directions and improve patient outcomes. The opportunity explicitly allows translational and clinical research, including clinical trials, which signals that the program is open to advanced-stage testing and validation when the rationale is strong and the path to clinical applicability is credible.

Because this is an "impact" mechanism, preliminary data are not optional. Applications must include feasibility-supporting evidence, and any unpublished preliminary results must come from the Principal Investigator's lab or from a member of the project team, underscoring the expectation that the investigators have already generated meaningful proof-of-concept work. The program also stresses continuity of research, meaning it is meant for established lines of investigation that have moved beyond basic research and are now poised to produce clinically relevant findings. In practice, that means reviewers will be looking for a coherent research trajectory: prior results that naturally lead into the proposed aims, a clear plan for what comes next, and a realistic timeline that supports near-term influence on clinical research or clinical practice.

Methodological rigor is another highlighted review priority. Proposed studies need to include a robust statistical plan and a clear data analysis strategy, with explicit attention to how the resulting evidence could translate into patient-relevant conclusions. This is not framed as a routine paperwork requirement; it is tied directly to the award's purpose of producing strong, interpretable outcomes that can move the field toward clinical adoption, inform trial design, or guide preventive or therapeutic strategies. Applicants are expected to demonstrate that the study design is sufficiently powered and analytically sound to yield results that can meaningfully shift decisions in research and care.

The announcement also makes military relevance a firm requirement. Proposed research must address at least one FY21 PRCRP Military Health Focus Area and be relevant to active-duty Service Members, Veterans, military beneficiaries, and/or the broader American public. The PRCRP describes a particular interest in building foundations in cancer areas that are underfunded, understudied, and/or especially lethal when they are also militarily relevant, so strong applications typically connect the cancer problem to military populations or exposures, gaps in current care for those communities, or broader readiness and long-term health considerations.

From an administrative standpoint, this FY21 opportunity was released by the Department of Defense, Department of the Army, U.S. Army Medical Research Acquisition Activity (USAMRAA). The funding opportunity number is W81XWH-21-PRCRP-IPA. It was offered as either a grant or a cooperative agreement under CFDA 12.420 (Science and Technology and other Research and Development). Eligibility is described as unrestricted (open to any type of entity, subject to any clarifications in the full notice). The opportunity was created March 24, 2021, with an original closing date of September 8, 2021, and the program anticipated making about 15 awards. The posted award ceiling is listed as 0 in the summary data, which typically indicates that applicants need to consult the full announcement for any practical budget limits or constraints.

Overall, the PRCRP Impact Award is best understood as a mechanism for teams that already have compelling evidence in hand and a well-developed project ready to tackle a high-importance cancer problem with immediate clinical relevance. Competitive proposals are expected to show a direct line from prior results to proposed next steps, leverage clinical samples and/or clinical trial infrastructure when appropriate, use rigorous statistical and analytical methods, and present a credible argument that the work can deliver significant, near-term improvements in cancer research direction and patient outcomes while meeting explicit military health relevance requirements.

• The Department of Defense, Dept. of the Army -- USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD Peer Reviewed Cancer, Impact Award" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
• This funding opportunity was created on Mar 24, 2021.
• Applicants must submit their applications by Sep 08, 2021. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 15 candidate(s).
• Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.

Apply for W81XWH 21 PRCRP IPA

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: